Your browser doesn't support javascript.
loading
Tetraspanin CD81, a modulator of immune suppression in cancer and metastasis.
Vences-Catalán, Felipe; Rajapaksa, Ranjani; Srivastava, Minu K; Marabelle, Aurelien; Kuo, Chiung-Chi; Levy, Ronald; Levy, Shoshana.
Afiliação
  • Vences-Catalán F; Department of Medicine, Division of Oncology, Stanford University Medical Center , Stanford, CA, USA.
  • Rajapaksa R; Department of Medicine, Division of Oncology, Stanford University Medical Center , Stanford, CA, USA.
  • Srivastava MK; Department of Medicine, Division of Oncology, Stanford University Medical Center , Stanford, CA, USA.
  • Marabelle A; Department of Medicine, Division of Oncology, Stanford University Medical Center , Stanford, CA, USA.
  • Kuo CC; Department of Medicine, Division of Oncology, Stanford University Medical Center , Stanford, CA, USA.
  • Levy R; Department of Medicine, Division of Oncology, Stanford University Medical Center , Stanford, CA, USA.
  • Levy S; Department of Medicine, Division of Oncology, Stanford University Medical Center , Stanford, CA, USA.
Oncoimmunology ; 5(5): e1120399, 2016 May.
Article em En | MEDLINE | ID: mdl-27467918
Cancer cells can escape the antitumor immune response by recruiting immune suppressor cells. However, although innate myeloid-derived suppressor cells (MDSCs) and T regulatory (Treg) cells accumulate normally in tumor-bearing CD81-deficient mice, both populations are impaired in their ability to suppress the antitumor immune response.
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncoimmunology Ano de publicação: 2016 Tipo de documento: Article